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Abstract. The diffusion of laryngeal cancer cells in the 
perineural space is a parameter associated with a negative 
prognosis, high loco-regional recurrence and low disease-free 
survival rates. The spread of tumor cells on the perineural 
sheath highlights the histopathological and clinically aggres-
sive behavior of this type of tumor, which may extend 
proximally or distally in the nerve for >10 cm. Therefore, 
the surgical resection margin is generally insufficient to treat 
patients with laryngeal cancer presenting with perineural inva-
sion (PNI) with surgery alone. In PNI, the minor laryngeal 
nerves are frequently involved, rather than the superior and 
inferior laryngeal nerves. The aim of the present study was: 
i) To evaluate the prognostic importance of PNI; ii) to correlate 
the rate of infiltration with factors associated with the tumor, 
including histotype, site and tumor-node-metastasis stage, 
and with the type of surgery (total or partial laryngectomy); 
and iii) to evaluate the rate of disease-free survival according 
to the outcome of combined surgery and radiotherapy (RT) 
treatment, by means of retrospective analysis. The results of 
the present study highlighted the importance of performing 
a closer clinical and instrumental follow-up in patients with 
laryngeal cancer whose histopathological examination is posi-
tive for PNI. In such cases, it is important to complement the 
surgical therapeutic treatment with adjuvant RT.
Introduction
Perineural invasion (PNI), also known as neurotropic carci-
nomatous spread, is a process predominantly characterized by 
neoplastic invasion of the nerves. PNI may also occur in the 
absence of lymphatic or vascular invasion (1-5).
In PNI, the propagation of neoplastic cells to the primitive 
site of the tumor does not occur via lymphatic dissemination, but 
through molecular mediators that guide these cells during the 
invasion of the nerve sheath (6). The definition of PNI was first 
proposed in a study by Batsakis (3), according to which, PNI 
was ‘a tumor cell invasion in, around and through the nerve’. 
Following multiple modifications, PNI is currently defined as 
‘the presence of tumor cells in the 3 layers of the nerve sheath’ 
or ‘in close proximity to nerve, involving at least 33% of its 
entire circumference’; below this cut-off, focal abutment rather 
than PNI should be considered (1,6).
The incidence of PNI has been reported to vary from 6 to 
50% for head and neck cancer, and <80% for squamocellular 
carcinoma. PNI is an independent negative prognostic factor 
associated with a lesser loco-regional control of the disease 
and poor survival in patients with laryngeal cancer (1,2,6-14). 
The aim of the present study was: i) To evaluate the prognostic 
importance and incidence of PNI; ii) to correlate the infiltration 
rate with factors associated to the tumor, including histotype, 
site and tumor-node-metastasis stage (TNM), and with the type 
of surgery (total or partial laryngectomy); iii) to evaluate the 
disease-free survival rate according to the outcome of combined 
surgery and radiotherapy (RT) treatment; and iv) to formulate 
a specific follow-up protocol for patients with laryngeal cancer 
and PNI, depending on the clinical and histopathological char-
acteristics of the tumor.
Patients and methods
Patients and treatment. The cohort in the present study consisted 
of 40 patients, 33 of which were male and 7 of which were 
female. The patients were selected by retrospective analysis of 
253 patients who had undergone surgical laryngectomy for laryn-
geal neoplasia at the Department of Neurosciences, Ear, Nose 
and Throat (ENT) Section, University of Naples ‘Federico II’ 
(Naples, Italy) between 2000 and 2011. The included patients 
(n=40) were selected from the total records (n=253) based on the 
following management inclusion criteria: i) Adjuvant RT treat-
ment (60-66 Gy; 2 Gy/day over 6.0-6.5 weeks); ii) oncological, 
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clinical and instrumental follow-up through visits and laryngos-
copy with optical fibers in the dedicated Ambulatory Centre, 
conducted monthly in the first year, every 3 months in the second 
year, and biannually from the third year; and iii) annual positron 
emission tomography-computed tomography (PET-CT) for 
locoregional and distant control of the disease. Patients with 
follow-up times of <12 months were excluded from the study. Of 
the 40 patients included in the study, 31 had been subjected to 
total laryngectomy (TL), 6 to supraglottic laryngectomy (SGL) 
and 3 to supracricoid laryngectomy (SCL). All patients were 
diagnosed with PNI, according to histological and immunohis-
tochemical examination, which revealed the presence of tumor 
cells invading the 3 nerve sheath layers or involving ≤33% of the 
entire circumference of the nerve. Written informed consent was 
obtained from all patients for inclusion in the present study. The 
study was approved by the ethics committee of ENT Section, 
University of Naples ‘Federico II’.
Statistical analysis. Statistical analysis was performed with 
MedCalc software, version 9.3.7.0 (MedCalc Software bvba, 
Ostend, West Flanders, Belgium) by scanning the quantitative 
variables with the standard functions. The disease-free survival 
rate was estimated with a Kaplan-Meier curve. P<0.05 was 
considered to indicate a statistically significant difference.
Results
Clinical and pathological characteristics. Of the 40 patients 
examined: i) 31 had undergone TL, 25 of which presented with 
neoformations that initially involved the vocal folds (10 T4N0, 
7 T3N0, 3 T4N1, 3 T4N2, 1 T3N1 and 1 T3N2). In 4 cases, the 
neoplasia involved the supraglottic region (3 T4N0 and 1 T3N0), 
and in 2 cases the presence of a glottis tumor with subglottic 
extension was observed (1 T3N0 and 1 T4N0). ii) 6 patients 
whose tumor involved the supraglottic area had undergone SGL 
(3 T4N0, 1 T3N0, 1 T3N1 and 1 T4N2). iii) 3 patients had under-
gone subtotal reconstructive laryngectomy (SRL), 2 of which 
presented with supraglottic (1 T4N0 and 1 T4N1) and 1 with 
glottic (1 T4N2) localization of the tumor.
The pathological tumor-node-metastasis (pTNM) analysis 
(Table I), was performed according to the criteria described in 
the 7th edition of the Union for International Cancer Control 
and American Joint Committee on Cancer (AJCC) staging 
system, published in 2010 (15), which classified 12 cases with 
disease stage III and 28 cases with disease stage IV. Microscopic 
analysis of the tumor specimens revealed the squamocellular 
histotype in 39 patients (97.5%; 29 G3 and 10 G2-G3), 12 of 
which exhibited basaloid characteristics, and only 1 patient with 
sarcomatoid histology (1 G3).
Survival. During the follow-up, 13 patients succumbed (mean 
time, 24 months post-treatment); 11 due to laryngeal cancer 
(3 T4NO, 3 T4N2, 2 T3N0, 1 T3N1, 1 T4N1 and 1 T3N2; 3 in 
stage III and 8 in stage IV), and 2 due to other causes (1 T4N0 
and 1 T3N0). The 11 patients who succumbed to the disease 
presented with locoregional recurrences of laryngeal cancer 
and/or laterocervical metastases that led to mortality a few 
months later. In addition, distant metastases were also noted in 
2 cases. Among these 11 mortalities, 7 patients had undergone 
TL, 3 SGL and 1 SRL. Furthermore, histological analysis 
revealed basaloid aspects of the tumor in 3 cases (2 T4N2 
and 1 T3N0). Of the remaining 27 patients, 22 underwent TL, 
3 SGL and 2 SRL. Additionally, 19 of these patients were in 
stage IV and 8 in stage III. These patients continued the clinical 
and instrumental oncological follow-up, and no clinical or 
radiological locoregional recurrence has been observed to date 
(Table II).
Statistical analysis. The statistical analysis indicated that the 
median survival time was 36 months for the patients in stage III 
Table I. Pathological tumor-node-metastasis analysis of patients with laryngeal cancer and perineural invasion, according to the 
Union for International Cancer Control and American Joint Committee on Cancer staging system.
 Total laryngectomy Supraglottic laryngectomy Supracricoid laryngectomy
 --------------------------------------------------------- -------------------------------------------------------- ---------------------------------------------------------
Patients T3 T4 Total T3 T4 Total T3 T4 Total
N0   9 14 23 1 3 4 - 1 1
N1   1   3   4 1 - 1 - 1 1
N2   1   3   4 - 1 1 - 1 1
N3 - - - - - - - - -
Total 11 20 31 2 4 6 - 3 3
Table II. Mortalities during follow-up.
Cause of mortality  No. of patients Pathological tumor-node-metastasis status, n Surgical procedure
Laryngeal cancer 11 3 T4N0, 1 T4N1, 3 T4N2, 2 T3N0, 1 T3N1, 1 T3N2 7 TL, 3 SGL, 1 SCL
Other causes   2 1 T4N0, 1 T3N0 2 TL
TL, total laryngectomy; SGL, supraglottic laryngectomy; SCL, supracricoid laryngectomy.
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and 30 months for those patients in stage IV and this difference 
was found to be statistically significant (P<0.05). Following 
18 months of treatment, the disease-free survival rate was 
100%, with an average follow-up time of 42.35 months.
Discussion
PNI represents an independent negative prognostic factor 
associated with increased locoregional recurrence and meta-
static laterocervical lymphadenopathies, which adversely 
affect the prognosis of patients with larynx cancer, in terms 
of overall and disease-free survival rates (1,2,6-8,10-14). In 
the 7th edition of the AJCC staging system for the classifica-
tion of squamous cell carcinomas, published in 2010, PNI was 
included among the high-risk factors for patients with laryn-
geal cancer (16). Previous studies by Soo et al (8) reported 
that the survival rate of patients with laryngeal cancer were 
reduced from 49 to 23% following 3 years of treatment if the 
patients developed PNI.
In the past, the pathogenic model of laryngeal cancer 
with PNI was considered to be associated with the lymphatic 
dissemination of tumor cells within the nerve (8). However, 
this model was later rejected, since the lymphatic channels do 
not penetrate the inner sanctum of the nerve sheath. Instead, 
it has now been proposed that tumor cells spread along neural 
sheaths in low-resistance planes, using the chemotactic effect 
of certain neurotrophic molecules, including nerve growth 
factor, brain-derived neurotrophic factor and neurotrophin-3, 
which guide the dissemination and invasion of these nerve 
cells through specific receptor sites (6).
Magnetic resonance imaging (MRI) with contrast has been 
suggested to be the best imaging method to detect PNI (11,17). 
Previous studies have demonstrated the preeminence of MRI 
high-field 3.0-T over traditional MRI 1.5 in spatial resolution, 
due to the higher signal intensity and the slight difference 
on contrastographic enhancement of nerves stumps (18-20). 
Therefore, a refinement of this radiological technique may 
offer a more sensitive pre-surgical determination of PNI, 
which nowadays requires the histological analysis of surgical 
samples (19).
The MRI analysis performed on 13 patients in the present 
study did not provide any additional information regarding 
PNI, compared with CT and PET-CT. Tumor cells invading 
the nerve sheaths may extend proximally or distally in the 
nerve overtaking the resection margins, which may overturn 
the significance of surgical resection, since tumor cells can 
spread anywhere between 2 and 12 cm from the tumor primi-
tive site without invading the intermediate nerve segments (7).
In previous studies, PNI exhibited a preference for growth 
along the nerves that infiltrated the intracranial fossa, in 
particular cranial nerve V. PNI may be incidental without 
symptoms, or may present clinically with lesions in the cranial 
nerves. The initial symptoms of PNI include paresthesia 
and formication, but may slowly progress to pain, numb-
ness and facial weakness (termed Bell's palsy or trigeminal 
neuralgia) (16).
PNI affects a small percentage of the ‘major’ nerves, 
including the laryngeal, hypoglossal, spinal and cervical 
plexuses (~2 vs. 33.5% of the so-called ‘minor’ nerves with 
a diameter of <1 mm) (11,13). Fagan et al (1) reported that 
nerves with a diameter of <0.2 mm were involved in 60% of 
PNI cases.
The College of American Pathologists (14) reported that 
the association between PNI and patient prognosis does not 
depend on the diameter of the nerves involved. This compli-
cates the pre-surgical identification of PNI through imaging 
and the histological analyses of these nerves. A number of 
studies have previously suggested that the appearance of 
distant lymph node metastases in patients with laryngeal 
cancer is due to the presence of PNI, which is usually asso-
ciated with worse locoregional control of the disease (14). 
Considering the impact on prognosis, the presence of PNI 
affects the therapeutic options and the decision making 
process in patients with laryngeal cancer. In this regard, adju-
vant radio-chemotherapy has been demonstrated to result in a 
better outcome in those patients presenting with PNI, in terms 
of recurrence, local control of the disease, overall survival and 
disease-free survival rates (2,14,16,21).
The optimal treatment for patients with resectable disease is 
possibly resection and post-operative RT, while those patients 
with unresectable cancer are generally treated with definitive 
RT (7,16). Tumor cells have the tendency to concentrate in 
the nerve periphery (known as the perinevrium), which is a 
hypoxic space due to its poor blood supply. This leads to low 
radiosensitivity in these areas, which may explain the failure 
of RT treatment observed in previous cases (11).
Previous studies have confirmed that patients with PNI 
whose nodes are clinically and instrumentally negative, exhibit 
an increased rate of spread to the regional nodes (1,2,16,21-24). 
In consequence, these patients should be subjected to elective 
neck dissection. Furthermore, since the dominant pattern of 
recurrence is local, strategies aimed to improve local control 
of the disease, such as chemotherapy, should be consid-
ered (1,2,16,21-24).
Miller et al (24) demonstrated an association between 
the extent of PNI and the disease-free survival time with a 
novel classification system of PNI subcategories, namely 
intratumoral, peripheral or extratumoral PNI, according to the 
distance in mm to the tumor edge.
The results of the present study suggested that the presence 
of PNI affects the prognosis of patients with laryngeal cancer, 
depending on the type of treatment received, the histotype of 
the tumor and the pTNM stage. Out of the 11 patients who 
succumbed to the disease in the present study (8 in stage IV 
and 3 in stage III), 7 cases (63.6%) had undergone TL, 3 SGL 
and 1 SRL. Of these 11 patients, 8 presented with a squamo-
cellular histotype (7 G3 and 1 G2-G3) and 3 with a basaloid 
histotype (2 G3 and 1 G2-G3). In addition, 6 patients presented 
with lymph node metastases. The prevalence of the disease at 
advanced stage, the high level of undifferentiated cells and the 
histopathological features associated with PNI, are suggestive 
of the high aggressiveness displayed by this type of cancer. The 
incidence of PNI in the present study was 15.81%. The median 
survival time of the 27 patients with laryngeal cancer who 
were subjected to surgery (22 TL vs. 5 partial laryngectomy) 
and continuous follow-up was 34 months, which highlights 
the requirement for a more aggressive surgical treatment and 
adjuvant RT in order to achieve higher overall and disease-free 
survival rates for laryngeal cancer patients affected by PNI. 
The survival rate observed in the present study was higher than 
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that reported in the literature (67.5 vs. 30-40% for patients with 
local advanced disease), which supports the therapeutic actions 
and the distance control strategies adopted in the present study.
In conclusion, the presence of PNI represents a valuable 
prognostic factor that establishes the low survival rates in 
patients with laryngeal cancer, and confirms the requirement 
for combined surgical and RT treatment in such patients. If 
monitored by a rigorous follow-up, the presence of PNI allows 
the identification of possible recurrences early, so as to establish 
appropriate salvage therapeutic protocols.
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